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ABSTRACT
OBJECTIVE: To determine the prevalence and associated access factors for all 
continued-use prescription drugs and the ways in which they can be obtained. 
METHODS: Data was obtained from the 2008 Household National Survey. 
The sample comprised 27,333 individuals above 60 years who reported that 
they used continued-use prescription drugs. A descriptive analysis and binary 
and multiple multinomial logistic regressions were performed. 
RESULTS: 86.0% of the older adults had access to all the medication they 
needed, and among them, 50.7% purchased said medication. Those who 
obtained medication from the public health system were younger (60-64 
years), did not have health insurance plans, and belonged to the lower income 
groups. It is remarkable that 14.0% of the subjects still had no access to any 
continued-use medication, and for those with more than four chronic diseases, 
this amount reached 22.0%. Those with a greater number of chronic diseases 
ran a higher risk of not having access to all the medication they needed. 
CONCLUSIONS: There are some groups of older adults with an increased 
risk of not obtaining all the medication they need and of purchasing it. The 
results of this study are expected to contribute to guide programs and plans 
for access to medication in Brazil.
DESCRIPTORS: Aged. Drug Utilization, economics. Drugs of 
Continuous Use. Pharmaceutical Preparations, supply & distribution. 
Population Surveys. 
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The aging of the population is a prominent global 
phenomenon.2,7 In Brazil, individuals above 65 
years represented 4.8% of the population in 1991; 
however, in 2010, this group comprised 7.4%.a The 
increase in the aging population has led to a greater 
frequency of chronic diseases; consequently, an 
increase in the demand for health services and medi-
cation.12,20 In the United States, it is estimated that 
approximately one-third of all medication used is 
for individuals above 60 years.21 In addition, studies 
show that the majority of older adults use more than 
one medication.11,18
Assuring access to essential medication for older 
adults has been a priority for the Brazilian Medication 
Policyb and the Statute for the Elderlyc since 2003. 
Thus, some of the initiatives of the Brazilian Unified 
RESUMO
OBJETIVO: Analisar a prevalência e fatores associados com o acesso a 
medicamentos de uso contínuo e formas de sua obtenção.
MÉTODOS: Foram obtidos dados da Pesquisa Nacional por Amostras em 
Domicílio de 2008. A amostra foi composta por 27.333 indivíduos com idade 
acima de 60 anos que reportaram utilizar medicamentos de uso contínuo. Foram 
utilizados modelos de regressão logística multinomial binário e múltipla para 
análise dos dados.
RESULTADOS: Tiveram acesso a todos os medicamentos 86,0% dos idosos, 
dos quais 50,7% os obtiveram por compra. Aqueles que os obtiveram do sistema 
público de saúde eram mais jovens (60-64 anos), não tinham plano de saúde e 
pertenciam a grupos com menor renda. Dos idosos que usam medicamentos de 
uso contínuo, 14,0% não receberam nenhum dos medicamentos; para aqueles 
com mais de quatro doenças crônicas esse valor chegou a 22,0%; aqueles com 
maior número de morbidades crônicas tiveram maior risco de não conseguir 
todos os medicamentos.
CONCLUSÕES: Alguns grupos de idosos apresentam risco aumentado de não 
obter todos os medicamentos necessários e de comprar todos os medicamentos. 
Esses resultados podem orientar programas e planos de acesso a medicamentos 
no Brasil.
DESCRITORES: Idoso. Uso de Medicamentos, economia. Medicamentos 
de Uso Contínuo. Preparações Farmacêuticas, provisão & distribuição. 
Inquéritos Demográficos
INTRODUCTION
Health System (SUS) have been performed for these 
purposes, such as the distribution of medication for 
Alzheimer or Parkinson’s disease,14 or the Programa 
Farmácia Popular (People’s Pharmacy Program) 
and the Programa Saúde Não Tem Preço (Health Has 
No Price Program),d which offer free medication for 
diabetes and hypertension.
Epidemiological research has discovered a high preva-
lence of medication use in older adults in Brazil, which 
varies5,8 based on socioeconomic characteristics and the 
seriousness of the disease.5 Thus, it is more difficult or 
impossible for certain groups to access said medica-
tion. This fact can contribute to problems such as the 
spending of an uneven amount of family income6 or 
under the use of necessary medication.13
a Instituto Brasileiro de Geografia e Estatística. Census first final results: Brazil has a population of 190,755,799 residents. Rio de Janeiro: IBGE; 
2010 [cited 2013 Feb 2]. Available from: http://saladeimprensa.ibge.gov.br/en/noticias?view=noticia&id=1&busca=1&idnoticia=1866
b Ministério da Saúde, Secretaria de Políticas de Saúde, Departamento de Formulação de Políticas de Saúde. Política nacional de 
medicamentos. Brasília (DF); 2001. (Série C. Projetos, Programas e Relatórios, 25).
c Brasil. Lei nº 10.741 de 1º de outubro de 2003. Dispõe sobre o Estatuto do Idoso e dá outras providências. Diario Oficial Uniao. 3 out 2003. 
Artigo 15, Seção V,§ 2o.
d Ministério da Saúde. Portaria nº 184, de 3 de fevereiro de 2011. Dispõe sobre o Programa Farmácia Popular no Brasil. Brasília (DF); 2011 
[cited 2014 Oct 9]. Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2011/prt0184_03_02_2011.html
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In 2009, Brazilian families spent 56.2 billion reals on 
medications.e A population-based study conducted in 
Florianópolis, SC, Southeastern Brazil, showed that 
the difference in the amount of income dedicated to the 
purchase of medications was four times higher for the 
poor when compared to the wealthier class.6 In turn, 
the underuse of medication can lead to worse clinical 
outcomes and a lower quality of life for patients. It also 
can increase their spending on secondary and tertiary 
care and often leads to the need for greater doses of 
medication, and consequently, a greater risk of adverse 
events.10,17
Data about access to medication are important tools for 
characterizing the health system15 and supporting poli-
cies and actions aimed at expanding access to priority 
groups. In this context, this study aimed to analyze the 
prevalence of continued-use prescription drugs and the 
factors associated with accessing and obtaining them.
METHODS
Data obtained from the National Household Survey 
(PNAD) in 2008f was used seeing that it was the most 
recent study containing health questions. The PNAD 
is a cross-sectional study with national coverage 
conducted annually with the aim of providing informa-
tion about the general characteristics of the population, 
such as education, work, and income.f
The PNAD sampling plan includes complex samples, 
incorporating the stratification of sampling units, 
conglomeration (sample selection in various stages, 
with compound sampling units), unequal selection 
probabilities in one or more stages, and adjustments 
made for the weighting of the sample to calibrate it 
with the total known population.
Of the 391,868 individuals studied in the PNAD in 
2008, those above 60 years who reported that they used 
continued-use prescription drugs were selected to partici-
pate in this study. They totaled 27,333 individuals.
The outcome variable was access to medication and 
was measured by the following questions:
• Question 1: “The last time that you needed con-
tinued-use prescription drugs, how many of them 
did you receive for free?” Response categories: All, 
Some, and None.
• Question 2: “Of the continued-use prescription 
drugs that you did not receive for free, how many 
of them did you have to buy?” Response categories: 
All, Some, and None.
The individuals were categorized by their type of access 
to medication based on their responses to these questions:
• Free – individuals who stated that they had recei-
ved all the medication for free, i.e., those who res-
ponded “all” to question 1.
• Purchasers – individuals who purchased all their 
medications, i.e., those who responded “none” to 
question 1 and “all” to question 2.
• Mixed – individuals who received some of their 
medication for free and purchased the rest, i.e., 
those who responded “some” to question 1 and 
“all” to questions 2.
• Partial or no access – individuals who only recei-
ved or purchased some of the medication they nee-
ded (either for free or through purchase) or did not 
receive or purchase any medication. This group 
includes those who responded “some” to ques-
tion 1 and “some” or “none” to question 2, as well 
as those who responded “none” to question 1 and 
“some” or “none” to question 2.
The group that responded as receiving the drugs for 
free was analyzed in this study as though they received 
SUS drugs. This is because they are used on a regular 
basis, and although some individuals may have received 
the drugs from friends, relatives, health plans, or 
another source, it is likely that these represent a small 
percentage of those who receive medication.
The independent variables were chosen according to the 
Andersen theoretical model1 (1995) and the availability 
of the PNAD. This model has often been used in studies 
investigating access to and use of health services.19
The independent variables were geographic region 
(North, Northeast, Southeast, South, and Midwest), 
age range (60-64, 65-69, 70-74, and ≥ 75 years), sex 
(feminine and masculine) location of home (urban 
and rural), perceived health status (good or very good, 
regular, and bad or very bad), number of morbidities 
stated (0, 1, 2-3, and ≥ 4), medical consultation in the 
last twelve months (yes or no), regularly seeks the 
same health service (yes or no), and income (group 1, 
group 2, and group 3). As for the reported morbidity 
variable, only the 12 morbidities investigated in the 
PNAD were included, i.e., spine diseases or back pain; 
arthritis or rheumatism, cancer, diabetes, bronchitis or 
asthma, hypertension, heart disease, chronic kidney 
failure, depression, tuberculosis, tendinitis or tenosy-
novitis, and cirrhosis.
e Instituto Brasileiro de Geografia e Estatística. Conta-satélite de Saúde Brasil - 2007-2009: despesas de consumo intermediário e final da 
administração pública: uma análise dos dados de medicamentos. Rio de Janeiro: IBGE; 2012. (Contas Nacionais, 37).
f Instituto Brasileiro de Geografia e Estatística. Pesquisa Nacional por Amostra de Domicílios 2008 - Suplemento. Rio de Janeiro: IBGE; 2009 
[cited 2013 Feb]. Available from: http://www.ibge.gov.br/home/estatistica/populacao/panorama_saude_brasil_2003_2008/
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The income group variable was constructed from the 
monthly family income per capita available on the 
National Household Survey database. The cutoff points 
for each income group were chosen to categorize three 
income groups, seeking greater homogeneity within the 
defined categories. The income groups were defined as 
group 1 – individuals with family income per capita 
above the 90th percentile, i.e., monthly family income 
greater than R$1,635.00, group 2 – family incomes 
between the 90th percentile and the 50th, i.e., monthly 
family income between R$460.00 and R$1,635.00, 
and group 3 – monthly per capita income below 
the 50th percentile, i.e., those with a family monthly 
per capita income less than R$460.00.g
Prevalence rates were estimated for each type of access 
to continued-use prescription drugs and for each type 
of access by income group.
The statistical association between the dependent and 
independent variables was assessed using the Chi-square 
test. The variables associated with the dependent vari-
able (p < 0.05) in the bivariate analysis were included 
in a multivariate multinomial logistic regression model.
Analyses were performed using SPSS for Windows 
software, version 17, and we took the sample weights 
and structural information of the sampling plan 
(conglomerates and stratification) into consideration. 
To maintain the use of sample size in the inferences 
made, corrected sample weights were used for adjust-
ment purposes (said weights were defined by the ratio 
between the natural weights of the design and their 
arithmetic mean).
RESULTS
Table 1 presents a description of the population studied 
and the frequency of each type of access, according to 
socioeconomic, demographic, and health variables. The 
majority of older adults who reported using continued-
use prescription drugs came from the Southeast and had 
the following characteristics: they were women, resided 
in urban areas, had health insurance plans, and had at 
least one chronic disease.
The majority (86.0%) of older adults had access to 
continued-use prescription drugs the last time they 
needed them. The Figure shows that the majority of 
older adults bought all their continued-use prescrip-
tion drugs the last time they needed them (41.6%), and 
14.1% of them did not have any access to the medica-
tion through health services. The majority of the latter 
group (14.1%) received some medication and bought 
the rest, 5.4% never obtained any medication, 3.2% 
did not receive any medication but bought some, and 
1.4% received some medication but did not buy any.
Those who belonged to income group 3 (lower income) 
and those living in rural areas had a higher prevalence 
of full free access to medication. On the other hand, in 
all of the other subgroups analyzed, the main method 
of access was by purchase. The groups whose individ-
uals with a higher prevalence of a total lack of access 
to medication reported that their health was bad or very 
bad, mainly belonged to income group 3 (lower income) 
and had four or more chronic diseases (Table 1).
Table 2 shows the results of the bivariate and multivar-
iate multinomial analyses, in which the group of indi-
viduals who received all their medication for free was 
compared to the other three groups, i.e., those who had 
full access by purchase, those who had mixed access, 
and who did not have full access. Given that they were 
deemed statistically significant in the bivariate anal-
ysis, all control variables were included in the multi-
variate analysis. Adjusted association measurements 
(Table 2) showed that the possibility of purchasing the 
medication, compared to those who received it all free 
of charge, was higher for older adults who had health 
insurance (OR = 7.4), belonged to older age groups, 
consulted at least one doctor in the last 12 months 
(OR = 0.9) and did not always return to the same health-
care service (OR = 0.7).
The possibility of having mixed access to medication was 
greater for older adults who had a worse state of health, 
a greater number of medical visits in the last 12 months, 
held health insurance plans, and belonged to the older age 
groups, when compared to those who had free access.
The possibility of not having full access, when 
compared to those who obtained all their medications 
for free, was greater for those who had a worse state of 
health, a greater number of morbidities, did not visit the 
same healthcare center, were in the older age groups, 
and were residents of the South or Southeast regions.
Out of all the variables tested, only the socioeconomic 
variable and the location of the household were statis-
tically significant. The measurements of the ratios of 
possibility of access to medication for these variables 
are presented in Table 3.
In the interaction (Table 3) analysis, the chance of 
purchasing all medications needed compared to 
receiving all for free was greater in urban areas, in 
income groups 1 and 2, and in income group 1, regard-
less of the location of the household. In income group 3 
(lowest income), there was no difference between urban 
and rural households. On the other hand, the possibility 
of having mixed access to medication compared to 
g Central Bank of Brazil. Currency conversion. [Internet]. Brasília (DF); 2008 [cited 2008 Jun 1]. Available from: http://www4.bcb.gov.br/pec/conversao/ 
5Rev Saúde Pública 2015;49:14
TT
ab
le
 1
. P
re
va
le
nc
e 
of
 th
e 
ty
pe
s 
of
 a
cc
es
s 
to
 m
ed
ic
at
io
n 
ba
se
d 
on
 s
oc
io
ec
on
om
ic
, d
em
og
ra
ph
ic
, a
nd
 h
ea
lth
ca
re
 v
ar
ia
bl
es
. B
ra
zi
l, 
20
08
.
V
ar
ia
bl
e
St
ud
y 
po
pu
la
tio
n
Fr
ee
 a
cc
es
s
A
cc
es
s 
by
 p
ur
ch
as
e
M
ix
ed
 a
cc
es
s
D
id
 n
ot
 h
av
e 
fu
ll 
ac
ce
ss
 
n 
%
Pr
ev
al
en
ce
 %
 
95
%
C
I
Pr
ev
al
en
ce
 %
 
95
%
C
I
Pr
ev
al
en
ce
 %
 
95
%
C
I
Pr
ev
al
en
ce
 %
 
95
%
C
I
A
ge
 r
an
ge
 (y
ea
rs
)
60
 to
 6
4
7,
57
3 
27
.7
33
.6
32
.3
;3
4.
9
42
.7
 
41
.3
;4
4.
2
10
.6
9.
7;
11
.5
13
.1
 
12
.2
;1
4.
0
65
 to
 6
9
6,
45
3
23
.3
34
.5
 3
3.
2;
35
.9
40
.8
39
.3
;4
2.
3
10
.6
 9
.7
;1
1.
7
14
.0
13
.0
;1
5.
1
70
 to
 7
4
5,
24
4
19
.2
30
.0
28
.6
;3
1.
5
42
.8
41
.1
;4
4.
5
11
.6
 
10
.6
;1
2.
8
15
.6
 
14
.3
;1
6.
9
≥ 
75
 
8,
06
3
29
.5
26
.9
 
25
.7
;2
8.
2
47
.0
 
45
.6
;4
8.
5 
11
.9
 
11
.0
;1
2.
8
14
.1
 
13
.1
;1
5.
2
Se
x M
as
cu
lin
e
10
,3
73
38
.0
32
.5
 
31
.0
;3
3.
6
43
.0
 
41
.8
;4
4.
2
10
.7
 9
.9
;1
1.
5
13
.8
 
12
.9
;1
4.
7
Fe
m
in
in
e
16
,9
60
62
.0
30
.4
 
29
.5
;3
1.
3
43
.9
 
42
.8
;4
4.
9
11
.5
 
10
.8
;1
2.
1
14
.3
 1
3.
6;
15
.0
R
eg
io
n
 
 
 
 
 
 
 
 
 
 
N
or
th
1,
08
6
4.
0
35
.8
 
33
.1
;3
8.
7
43
.4
 4
0.
4;
46
.4
7.
5 
6.
4;
8.
9
13
.3
 
11
.5
;1
5.
2
N
or
th
ea
st
6,
11
8
22
.4
39
.1
 
37
.3
;4
0.
9
39
.2
 3
7.
4;
41
.1
10
.3
 
9.
2;
11
.5
11
.3
10
.3
;1
2.
5
So
ut
he
as
t
13
,8
52
 
50
.6
28
.0
 
26
.9
;2
9.
2
46
.1
 
44
.6
;4
7.
6
10
.5
 
9.
6;
11
.4
15
.4
 
14
.4
;1
6.
5
So
ut
h
4,
54
0 
17
.0
29
.1
 
27
.0
;3
1.
3
41
.9
 
39
.5
;4
4.
2
15
.1
 
13
.3
;1
7.
1
13
.9
 
12
.5
;1
5.
5
M
id
w
es
t
1,
64
7
6.
0
31
.2
 
28
.9
;3
3.
6 
43
.1
 
40
.5
;4
5.
8
11
.3
 
9.
7;
13
.1
14
.4
 
12
.5
;1
6.
5
Lo
ca
tio
n
U
rb
an
23
,5
83
86
.3
29
.6
28
.7
;3
0.
4
45
.3
 4
4.
3;
46
.3
10
.9
10
.2
;1
1.
5
14
.3
 
13
.6
;1
5.
0
R
ur
al
3,
75
0
13
.7
41
.3
 
39
.0
;4
3.
6
32
.7
 
30
.4
;3
5.
1
13
.0
 1
1.
3;
14
.8
13
.0
11
.5
;1
4.
8
C
on
tin
ue
6 Access to medication in Brazil Viana KP et al
C
on
tin
ua
tio
n
In
co
m
e 
gr
ou
p
1
2,
56
8
9.
4
9.
9
 8
.7
;1
1.
2
76
.4
 
74
.5
;7
8.
3
4.
7 
4.
0;
5.
6
9.
0 
7.
8;
10
.3
2
10
,8
48
39
.6
26
.0
 
24
.9
;2
7.
2
49
.3
 
48
.0
;5
0.
6
11
.4
 
10
.5
;1
2.
3
13
.3
 
12
.5
;1
4.
2
3
12
,7
00
46
.5
41
.9
 
40
.7
;4
3.
0
28
.9
 
27
.8
;3
0.
1
12
.9
12
.1
;1
3.
8
16
.3
 
15
.4
;1
7.
3
M
is
si
ng
1,
21
6
4.
2
 
 
 
 
 
 
 
 
H
el
d 
a 
he
al
th
ca
re
 p
la
n
 
 
 
 
 
 
 
 
 
 
Ye
s
9,
44
6
34
.6
13
.2
12
.4
;1
4.
1
68
.7
 6
7.
2;
69
,9
7.
9 
7.
2;
8.
7
10
.2
 
9.
3;
11
.1
N
o
17
,8
87
 
65
.4
40
.7
 
39
.7
;4
1.
7
30
.3
 
29
.3
;3
1.
3
12
.9
 
12
.1
;1
3.
6
16
.2
 
15
.4
;1
7.
0
V
is
ite
d 
a 
m
ed
ic
al
 p
ro
fe
ss
io
na
l i
n 
th
e 
pa
st
 1
2 
m
on
th
s
Ye
s
24
,9
07
 
91
.1
30
.9
 
30
.0
;3
1.
7
42
.9
41
.9
;4
3.
8
11
.7
 1
1.
1;
12
.4
14
.5
 
13
.9
;1
5.
2
N
o
2,
42
5 
8.
9
34
.5
 3
2.
3;
36
.8
50
.7
 
48
.3
;5
3.
1
5.
2
 4
.3
;6
.3
9.
6 
8.
3;
11
.1
N
or
m
al
ly
 v
is
its
 th
e 
sa
m
e 
he
al
th
ca
re
 s
er
vi
ce
Ye
s
22
,0
14
 
80
.5
32
.2
 
31
.3
;3
3.
1
42
.2
41
.2
;4
3.
3
11
.5
 
10
.8
;1
2.
2
14
.1
 1
3.
4;
14
.8
N
o
5,
31
9 
19
.5
26
.9
 
25
.3
;2
8.
5 
49
.0
 
47
.2
;5
0.
7
9.
9 
8.
9;
10
.9
14
.3
 1
3.
1;
15
.6
Pe
rc
ei
ve
d 
st
at
e 
of
 h
ea
lth
 
 
 
 
 
 
 
 
 
 
G
oo
d 
or
 v
er
y 
go
od
9,
83
7 
36
.0
29
.8
28
.6
;3
1.
1 
54
.4
 5
3.
0;
55
.8
 
6.
7 
6.
1;
7.
3
9.
1
 8
.4
;9
.9
N
or
m
al
12
,8
12
 
46
.9
33
.1
 
32
.0
;3
4.
1
39
.4
 
38
.2
;4
0.
6
12
.1
11
.3
;1
2.
9
15
.5
 1
4.
6;
16
.4
B
ad
 o
r 
ve
ry
 b
ad
4,
66
8 
17
.1
28
.9
 
27
.3
;3
0.
5
32
.2
 3
0.
5;
33
.8
18
.1
16
.7
;1
9.
5
20
.9
 
19
.5
;2
2.
4
N
um
be
r 
of
 m
or
bi
di
tie
s 
re
po
rt
ed
N
on
e
1,
84
0 
6.
7
21
.1
 
19
.1
;2
3.
3
65
.2
 
62
.6
;6
7.
7
5.
7 
4.
6;
7.
1
8.
0 
6.
7;
9.
5
1
7,
82
1 
28
.7
36
.9
 
35
.6
;3
8.
2
46
.9
 4
5.
5;
48
.4
6.
8
 6
.2
;7
.5
9.
4 
8.
6;
10
.2
3 
to
 4
12
,9
31
 
47
.3
32
.1
 
31
.0
;3
3.
2
40
.9
39
.8
;4
2.
1
12
.0
11
.2
;1
2.
9
15
.0
 
14
.1
;1
5.
8
≥ 
4
4,
44
1 
17
.3
23
.2
 
21
.9
;2
4.
7
36
.7
35
.0
;3
8.
4
18
.1
 1
6.
7;
19
.6
22
.0
 
20
.5
;2
3.
5
7Rev Saúde Pública 2015;49:14
Figure. Prevalence of the type of access to continued-use 
medication by older adults.
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having free access did not present a large difference in 
regards to region for all income groups. The possibility 
of not having full access compared to that of acquiring 
medication for free was less for the members of income 
group 1 living in urban areas (OR = 0.4).
DISCUSSION
The results of this study showed that a significant 
proportion of older adults who use medication regu-
larly had access to medication the last time they needed 
it. However, these results were different between 
subgroups of varying socioeconomic levels, demo-
graphic regions, and state of health. Furthermore, 
more than 50.0% of the older adults who had access to 
medication purchased all the medication they needed. 
A significant percentage of older adults (86.0%) had 
access to all the continued-use prescription drugs the 
last time they needed them roughly the same as has 
been found in other studies, despite the differences in 
methodologies used.8,15 As has already been mentioned, 
this prevalence varied between subgroups. The lack of 
access to medication, which affected 14.0% of older 
adults, reached 22.0% in older adults who had four or 
more chronic diseases.
Ensuring access to medication is considered one of 
the millennium goals and has often been discussed in 
the literature.16 Consequently, understanding the aging 
population (which is the main consumer of medica-
tions) in terms of their access to and use of drugs is 
extremely important when trying to achieve this goal. 
Thus, the results of this study showed that the older 
adults who were in the group that did not receive all 
their medications had worse states of health, (a greater 
number of chronic diseases and a worse perceived state 
of health) and were in older age ranges than those who 
had free access. This could be due to the fact that the 
public health system only offers treatment and medi-
cation for certain types of illnesses, which inherently 
deprives some patients of the possibility of obtaining 
medication for at least one disease.
The majority of older adults bought all or part of their 
continued-use prescription drugs, a fact that was already 
highlighted in the medical literature.5 In this study, 
approximately 29.0% of the older adults who belonged 
to the lowest income group (Group 3) bought all their 
continued-use prescription drugs the last time they 
needed them, which could certainly compromise their 
household incomes, even for basic needs.
The possibility of purchasing medication was greater 
for those who lived in urban areas and belonged to the 
higher income groups (Groups 1 and 2). This may be 
due to the fact that urban areas have more pharma-
cies than rural areas. However, different factors could 
also lead individuals to purchase medication instead 
of accessing public healthcare services, such as a lack 
of availability of medication through public chan-
nels, which appears to be the cause of the problem.5 
Furthermore, the availability of generic medications in 
the public healthcare system is lower than expected, and 
consequently, patients tend to purchase their medication 
in private pharmacies.5 However, the individuals who 
reported purchasing medications may be buying them 
at a low price via the People’s Pharmacy Program. The 
inability to differentiate this group in the analysis is a 
limitation of this study.
Access to medications was associated with state of 
health and sociodemographic variables. In general, when 
compared with the other groups, individuals who had free 
access were in the youngest age range of older adults, 
returned more often to the same places for health care, 
had consulted a doctor in the last 12 months, and did not 
have health insurance. These results are similar to what 
was found in other studies that characterized the popu-
lation that received free medications through the SUS.3,4
The absence of a recall period is also a limitation to 
this study, and it does not allow for comparability with 
other studies and may not capture the full scale of the 
problem, since it does not define how long the patients 
may be without their medication. The group that 
reported obtaining all their medication free of charge is 
also a limiting factor because of the fact that although 
they have been categorized as using the SUS, there may 
be other older adults in the group who received the free 
medication by other means.
Income has been identified as one of the single best 
indicators of lifestyle in epidemiological studies.9 
Nevertheless, due to the lack of a clear definition of the 
best cut-off point for the division of income groups in 
Brazil, the cut-off points used were chosen in order to 
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Table 2. Crude and adjusted odds ratios of factors associated with access to continued-use prescription drugs.* 
Variable
 Purchased all medication Mixed access Did not have full access
 
OR 95%CI ORaj 95%CI OR 95%CI ORaj 95%CI OR 95%CI ORaj 95%CI
Age range (years)         
60 to 64 1.0 1.0 1.0  1.0  1.0  1.0  
65 to 69 0.9 0.8;1.0 1.0 0.9;1.1 0.9 0.8;1.0 1.0 0.8;1.1 1.0 0.8;1.2 1.0 0.9;1.2
70 to 74 1.1 0.9;1.2 1.2 1.1;1.3 1.2 1.0;1.4 1.2 1.1;1.4 1.4 1.2;1.6 1.3 1.1;1.5
≥ 75 1.3 1.2;1.4 1.5 1.4;1.6 1.4 1.2;1.6 1.4 1.2;1.6 1.3 1.1;1.5 1.3 1.2;1.5
Sex         
Feminine 1.1 1.0;1.1 1.1 1.0;1.2 1.1 1.0;1.1 1.1 1.0;1.2 1.1 1.0;1.2 1.1 1.0;1.2
Masculine 1.0 1.0 1.0  1.0  1.0  1.0  
Region         
North 1.0 1.0 1.0  1.0  1.0  1.0  
Northeast 0.9 0.8;1.1 0.8 0.7;1.0 1.4 1.1;1.9 1.3 1.0;1.7 0.9 0.7;1.2 0.8 0.7;1.0
Southeast 1.5 1.2;1.7 0.8 0.7;0.9 1.8 1.4;2.4 1.7 1.3;2.1 1.7 1.3;2.2 1.3 1.1;1.6
South 1.3 1.1;1.6 0.8 0.6;0.9 2.4 1.8;3.3 2.3 1.8;3.0 1.4 1.1;1.9 1.2 1.0;1.5
Midwest 1.2 1.0;1.5 0.8 0.6;1.0 2.0 1.4;2.7 1.6 1.2;2.1 1.5 1.1;2.0 1.1 0.9;1.4
Household location
Urban 1.9 1.6;2.1 0.9 0.8;1.0 1.1 0.9;1.3 0.9 0.8;1.1 1.5 1.3;1.8 1.2 1.0;1.4
Rural 1.0 1.6;2.1 1.0 1.0  1.0  1.0  1.0  
Income group         
1 21.3 17.5;26.0 5.0 2.5;10.2 2.3 1.7;3.0 1.5 0.5;4.7 3.2 2.5;4.2 2.7 1.0;7.5
2 2.7 2.5;4.2 1.3 1.1;1.7 1.4 1.3;1.6 1.1 0.9;1.4 1.3 1.2;1.5 1.2 0.9;1.6
3 1.0 1.0 1.0  1.0  1.0  1.0  
Holds a healthcare plan
Yes 7.8 7.0;8.7 4.3 3.9;4.7 2.0 1.7;2.4 1.7 1.4;1.9 2.1 1.8;2.4 1.5 1.3;1.8
No 1.0 1.0 1.0  1.0  1.0  1.0  
Visited a medical professional in the last 12 months
Yes 0.9 0.8;1.0 0.7 0.6;0.8 2.5 2.0;3.1 1.9 1.6;2.4 1.7 1.4;2.0 1.3 1.1;1.3
No 1.0 1.0 1.0  1.0  1.0  1.0  
Normally visits the same healthcare service
Yes 0.7 0.6;0.8 0.6 0.6;0.7 0.9 0.8; 1.1 0.8 0.7;1.0 0.8 0.7;0.9 0.7 0.6;0.8
No 1.0 1.0 1.0  1.0  1.0  1.0  
Perceived state of health 
Good or very good 1.0 1.0 1.0  1.0  1.0  1.0  
Normal 0.6 0.6;0.7 1.0 0.9;1.0 1.7 1.5;2.0 1.5 1.3;1.7 1.6 1.4;1.8 1.5 1.3;1.7
Bad or very bad 0.6 0.5;0.7 1.1 1.0;1.2 2.7 2.3;3.2 2.4 2.1;2.8 2.4 2.1;2.7 2.2 1.9;2.5
Number of morbidities reported
None 1.0 1.0 1.0  1.0  1.0  1.0  
Only 1 0.4 0.3;0.5 0.5 0.4;0.6 1.1 0.5;1.0 0.7 0.6;0.9 1.3 0.5;0.9 0.7 0.6;0.9
3 to 4 0.4 0.3;0.4 0.5 0.4;0.6 1.1 1.0;2.0 1.2 1.0;1.6 1.3 0.9;1.7 1.2 1.0;1.5
≥ 4 0.5 0.4;0.6 0.6 0.5;0.7 2.8 1.9;4.0 2.1 1.6;2.7 2.7 2.0;3.7 2.0 1.6;2.6
* In the bivariate and multivariate multinomial analysis, the group that obtained all drugs free of charge was compared to the 
other groups.
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categorize three different income groups with established 
proportions. However, it is possible that the values used 
did not fully reflect Brazilian economic groups.
Another limitation of the study is that people tend to 
underestimate their drug needs;4 therefore, the results 
about necessary medication that was not obtained 
should be interpreted with caution.4
This study provides nationally representative data on 
the prevalence of the types of access to medication 
and investigates possible factors associated with each 
type of access. It indicates that there are still older 
adults who did not have full access to continued-use 
prescription drugs the last time they needed them, 
and even more significantly, that those in lower 
income groups continue buying the medication they 
need. In conclusion, it is expected that this study will 
be able to guide actions aimed at achieving greater 
availability and quality of pharmaceutical care in the 
public health system in Brazil.
Table 3. Odds ratio adjusted for comparison among household location, socioeconomic status, and the type of access to 
continued-use prescription drugs. Brazil, 2008.*
Group Adjusted odds ratio (OR) 
 
Income group
Full access by purchase Mixed access Did not have full access
 
Urban Rural Urban Rural Urban Rural
Group 1 12.6 5.4 0.3 0.4 0.4 0.9
Group 2 2.5 1.4 0.8 1.0 0.7 1.0
Group 3 1.0 1.0 1.0 1.0 1.0 1.0
* Reference groups: Free full access and income group 3. Group 1: Monthly family income per capita ≥ R$1,635.00, Group 2: 
per capita monthly income between R$460.00 and R$1,635.00, and Group 3: Monthly family income R$460.00.
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